Research & Education
CURE Expert Connections
CURE Speaking Out
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Self-Testing for HPV Could Help Reduce Cervical Cancer Rates
A new study suggests distributing self-testing kits by mail helps bring effective testing to underserved populations and makes it easier for women to get tested on their own time.
At-Home Urine Test Could Replace Pap Smear for Cervical Pre-Cancer Screening
Results from a new study suggest there may be a simpler, cheaper, more accessible way to screen for cervical pre-cancer.
Examining Genomics in the Treatment of Cervical Cancer
Researchers from Yale Cancer Center have created a platform to identify genetic mutations that might drive cervical cancer.
Clinical Trial Is Enrolling Patients With Cervical Cancer for Investigational Immunotherapy
Patients with recurrent, metastatic or persistent cervical cancer may benefit from the TIL immunotherapy LN-145.
Combination Immunotherapy Shows Promise in Cervical Cancer
Patients with recurrent or metastatic cervical cancer were treated with combination Opdivo and Yervoy in the CheckMate-358 clinical trial.
A Calming Spirit
Stephanie Fraser, M.S.W.
A essay nominating Kimberly Spina, B.S.N., RN for
®’s Extraordinary Healer® Award, written by Stephanie Fraser, M.S.W., of The University of Vermont Cancer Center.
CURE's Top 5 Stories: January 2019
Here are the top 5 CURE stories for January 2019.
Patients With Gynecologic Cancers Want to Discuss Sexual Health
Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.
Know the Facts: Cervical Cancer
In conjunction with Cervical Cancer Awareness Month, recognized in the month of January, here are some fast facts about the disease.
FDA Approves Age Expansion of HPV Vaccine
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
Not a member?
Sign up now!
Continue without login